The Rho Exchange Factors Vav2 and Vav3 Favor Skin Tumor Initiation and Promotion by Engaging Extracellular Signaling Loops

PLoS Biology

Volumn 11, Issue 7, 2013, Pages

  Menacho Márquez, Mauricio ^a   García Escudero, Ramón ^b   Ojeda, Virginia ^a   Abad, Antonio ^a   Delgado, Pilar ^c   Costa, Clotilde ^b   Ruiz, Sergio ^a   Alarcón, Balbino ^c   Paramio, Jesús M ^b   Bustelo, Xosé R ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b CIEMAT   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN VAV2; PROTEIN VAV3; UNCLASSIFIED DRUG; VAV PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CELL PROLIFERATION; CELL SURVIVAL; CONTROLLED STUDY; EXTRACELLULAR SPACE; GENETIC ENGINEERING; INTRACELLULAR SIGNALING; KERATINOCYTE; MITOGENESIS; MOUSE; NEWBORN; NONHUMAN; NUCLEOTIDE SEQUENCE; PARACRINE SIGNALING; PROTEIN DETERMINATION; PROTEIN FUNCTION; SKIN CARCINOGENESIS; SKIN TUMOR; TRANSCRIPTOMICS; TUMOR PROMOTION;

ANIMALS; CELL PROLIFERATION; KERATINOCYTES; MICE; MICE, KNOCKOUT; PROTO-ONCOGENE PROTEINS C-VAV; SIGNAL TRANSDUCTION; SKIN NEOPLASMS;

EID: 84880960770     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.1001615     Document Type: Article

References (53)

1. Bos JL, Rehmann H, Wittinghofer A, (2007) GEFs and GAPs: critical elements in the control of small G proteins. Cell 129: 865-877.
2. Rossman KL, Der CJ, Sondek J, (2005) GEF means go: turning on RHO GTPases with guanine nucleotide-exchange factors. Nat Rev Mol Cell Biol 6: 167-180.
3. Vigil D, Cherfils J, Rossman KL, Der CJ, (2010) Ras superfamily GEFs and GAPs: validated and tractable targets for cancer therapy? Nat Rev Cancer 10: 842-857.
4. Malliri A, van der Kammen RA, Clark K, van der Valk M, Michiels F, et al. (2002) Mice deficient in the Rac activator Tiam1 are resistant to Ras-induced skin tumours. Nature 417: 867-871.
5. Malliri A, Rygiel TP, van der Kammen RA, Song JY, Engers R, et al. (2006) The rac activator Tiam1 is a Wnt-responsive gene that modifies intestinal tumor development. J Biol Chem 281: 543-548.
6. Kawasaki Y, Tsuji S, Muroya K, Furukawa S, Shibata Y, et al. (2009) The adenomatous polyposis coli-associated exchange factors Asef and Asef2 are required for adenoma formation in Apc(Min/+)mice. EMBO Rep 10: 1355-1362.
7. Chang KH, Sanchez-Aguilera A, Shen S, Sengupta A, Madhu MN, et al. (2012) Vav3 collaborates with p190-BCR-ABL in lymphoid progenitor leukemogenesis, proliferation and survival. Blood 120: 800-811.
8. Lindsay CR, Lawn S, Campbell AD, Faller WJ, Rambow F, et al. (2011) P-Rex1 is required for efficient melanoblast migration and melanoma metastasis. Nat Commun 2: 555.
9. Bustelo XR, (2000) Regulatory and signaling properties of the Vav family. Mol Cell Biol 20: 1461-1477.
10. Kuhne MR, Ku G, Weiss A, (2000) A guanine nucleotide exchange factor-independent function of Vav1 in transcriptional activation. J Biol Chem 275: 2185-2190.
11. Saveliev A, Vanes L, Ksionda O, Rapley J, Smerdon SJ, et al. (2009) Function of the nucleotide exchange activity of Vav1 in T cell development and activation. Sci Signal 2: ra83.
12. Caloca MJ, Zugaza JL, Bustelo XR, (2008) Mechanistic analysis of the amplification and diversification events induced by Vav proteins in B-lymphocytes. J Biol Chem 283: 36454-36464.
13. Zugaza JL, Lopez-Lago MA, Caloca MJ, Dosil M, Movilla N, et al. (2002) Structural determinants for the biological activity of Vav proteins. J Biol Chem 277: 45377-45392.
14. Crespo P, Schuebel KE, Ostrom AA, Gutkind JS, Bustelo XR, (1997) Phosphotyrosine-dependent activation of Rac-1 GDP/GTP exchange by the vav proto-oncogene product. Nature 385: 169-172.
15. Schuebel KE, Movilla N, Rosa JL, Bustelo XR, (1998) Phosphorylation-dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2. Embo J 17: 6608-6621.
16. Movilla N, Bustelo XR, (1999) Biological and regulatory properties of Vav-3, a new member of the Vav family of oncoproteins. Mol Cell Biol 19: 7870-7885.
17. Citterio C, Menacho-Marquez M, Garcia-Escudero R, Larive RM, Barreiro O, et al. (2012) The Rho exchange factors Vav2 and Vav3 control a lung metastasis-specific transcriptional program in breast cancer cells. Science Signaling 5: ra71.
18. Turner M, Billadeau DD, (2002) VAV proteins as signal integrators for multi-subunit immune-recognition receptors. Nat Rev Immunol 2: 476-486.
19. Sauzeau V, Sevilla MA, Rivas-Elena JV, de Alava E, Montero MJ, et al. (2006) Vav3 proto-oncogene deficiency leads to sympathetic hyperactivity and cardiovascular dysfunction. Nat Med 12: 841-845.
20. Sauzeau V, Horta-Junior JAC, Riolobos AS, Fernandez G, Sevilla MA, et al. (2010) Vav3 is involved in GABAergic axon guidance events important for the proper function of brainstem neurons controlling cardiovascular, respiratory, and renal parameters. Mol Biol Cell 21: 4251-4263.
21. Quevedo C, Sauzeau V, Menacho-Marquez M, Castro-Castro A, Bustelo XR, (2011) Vav3-deficient mice exhibit a transient delay in cerebellar development. Mol Biol Cell 21: 1125-1139.
22. Cowan CW, Shao YR, Sahin M, Shamah SM, Lin MZ, et al. (2005) Vav family GEFs link activated Ephs to endocytosis and axon guidance. Neuron 46: 205-217.
23. Sauzeau V, Jerkic M, Lopez-Novoa JM, Bustelo XR, (2007) Loss of Vav2 proto-oncogene causes tachycardia and cardiovascular disease in mice. Mol Biol Cell 18: 943-952.
24. Sauzeau V, Sevilla MA, Montero MJ, Bustelo XR, (2010) The Rho/Rac exchange factor Vav2 controls nitric oxide-dependent responses in mouse vascular smooth muscle cells. J Clin Invest 120: 315-330.
25. Hunter SG, Zhuang G, Brantley-Sieders D, Swat W, Cowan CW, et al. (2006) Essential role of Vav family guanine nucleotide exchange factors in EphA receptor-mediated angiogenesis. Mol Cell Biol 26: 4830-4842.
26. Lomas A, Leonardi-Bee J, Bath-Hextall F, (2012) A systematic review of worldwide incidence of non-melanoma skin cancer. Br J Dermatol in press.
27. Quintanilla M, Brown K, Ramsden M, Balmain A, (1986) Carcinogen-specific mutation and amplification of Ha-ras during mouse skin carcinogenesis. Nature 322: 78-80.
28. Abel EL, Angel JM, Kiguchi K, DiGiovanni J, (2009) Multi-stage chemical carcinogenesis in mouse skin: fundamentals and applications. Nat Protoc 4: 1350-1362.
29. Rho O, Kim DJ, Kiguchi K, Digiovanni J, (2011) Growth factor signaling pathways as targets for prevention of epithelial carcinogenesis. Mol Carcinog 50: 264-279.
30. Rundhaug JE, Fischer SM, (2010) Molecular mechanisms of mouse skin tumor promotion. Cancers (Basel) 2: 436-482.
31. Wang Z, Pedersen E, Basse A, Lefever T, Peyrollier K, et al. (2010) Rac1 is crucial for Ras-dependent skin tumor formation by controlling Pak1-Mek-Erk hyperactivation and hyperproliferation in vivo. Oncogene 29: 3362-3373.
32. Benitah SA, Frye M, Glogauer M, Watt FM, (2005) Stem cell depletion through epidermal deletion of Rac1. Science 309: 933-935.
33. Castilho RM, Squarize CH, Patel V, Millar SE, Zheng Y, et al. (2007) Requirement of Rac1 distinguishes follicular from interfollicular epithelial stem cells. Oncogene 26: 5078-5085.
34. Chrostek A, Wu X, Quondamatteo F, Hu R, Sanecka A, et al. (2006) Rac1 is crucial for hair follicle integrity but is not essential for maintenance of the epidermis. Mol Cell Biol 26: 6957-6970.
35. Kazanietz MG, Bustelo XR, Barbacid M, Kolch W, Mischak H, et al. (1994) Zinc finger domains and phorbol ester pharmacophore. Analysis of binding to mutated form of protein kinase C zeta and the vav and c-raf proto-oncogene products. J Biol Chem 269: 11590-11594.
36. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, et al. (1993) Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 268: 9194-9197.
37. Calautti E, Missero C, Stein PL, Ezzell RM, Dotto GP, (1995) fyn tyrosine kinase is involved in keratinocyte differentiation control. Genes Dev 9: 2279-2291.
38. Quigley DA, To MD, Perez-Losada J, Pelorosso FG, Mao JH, et al. (2009) Genetic architecture of mouse skin inflammation and tumour susceptibility. Nature 458: 505-508.
39. Ancrile B, Lim KH, Counter CM, (2007) Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. Genes Dev 21: 1714-1719.
40. Lawson CD, Donald S, Anderson KE, Patton DT, Welch HC, (2011) P-Rex1 and Vav1 cooperate in the regulation of formyl-methionyl-leucyl-phenylalanine-dependent neutrophil responses. J Immunol 186: 1467-1476.
41. Erez N, Truitt M, Olson P, Arron ST, Hanahan D, (2010) Cancer-associated fibroblasts are activated in incipient neoplasia to orchestrate tumor-promoting inflammation in an NF-kappaB-dependent manner. Cancer Cell 17: 135-147.
42. Tlsty TD, Coussens LM, (2006) Tumor stroma and regulation of cancer development. Annu Rev Pathol 1: 119-150.
43. Mantovani A, Allavena P, Sica A, Balkwill F, (2008) Cancer-related inflammation. Nature 454: 436-444.
44. Faruqi TR, Gomez D, Bustelo XR, Bar-Sagi D, Reich NC, (2001) Rac1 mediates STAT3 activation by autocrine IL-6. Proc Natl Acad Sci U S A 98: 9014-9019.
45. Hirano T, Ishihara K, Hibi M, (2000) Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors. Oncogene 19: 2548-2556.
46. Ratushny V, Gober MD, Hick R, Ridky TW, Seykora JT, (2012) From keratinocyte to cancer: the pathogenesis and modeling of cutaneous squamous cell carcinoma. J Clin Invest 122: 464-472.
47. Sauzeau V, Carvajal-Gonzalez JM, Riolobos AS, Sevilla MA, Menacho-Marquez M, et al. (2011) Transcriptional factor aryl hydrocarbon receptor (Ahr) controls cardiovascular and respiratory functions by regulating the expression of the Vav3 proto-oncogene. J Biol Chem 286: 2896-2909.
48. Doody GM, Bell SE, Vigorito E, Clayton E, McAdam S, et al. (2001) Signal transduction through Vav-2 participates in humoral immune responses and B cell maturation. Nat Immunol 2: 542-547.
49. Turner M, Mee PJ, Walters AE, Quinn ME, Mellor AL, et al. (1997) A requirement for the Rho-family GTP exchange factor Vav in positive and negative selection of thymocytes. Immunity 7: 451-460.
50. Berenjeno IM, Nunez F, Bustelo XR, (2007) Transcriptomal profiling of the cellular transformation induced by Rho subfamily GTPases. Oncogene 26: 4295-4305.
51. Bolstad BM, Irizarry RA, Astrand M, Speed TP, (2003) A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 19: 185-193.
52. Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
53. Pavlidis P, Noble WS, (2001) Analysis of strain and regional variation in gene expression in mouse brain. Genome Biol 2Research0042.0041-0042.0015.